Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.29271/jcpsp.2018.04.334 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Rare Case Report of Sitagliptin-Induced Angioedema.
Cureus
October 2022
Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, is used for the treatment of type 2 diabetes mellitus. Sitagliptin-induced angioedema has increased with the simultaneous use of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors. We present a rare case of a 50-year-old female diagnosed with sitagliptin-induced angioedema.
View Article and Find Full Text PDFSitagliptin-induced Achilles enthesopathy: Case report and literature review.
Eur J Rheumatol
April 2022
Department of Rheumatology, Gaziantep Medicalpark Hospital, Şehitkamil, Gaziantep, Turkey.
Achilles enthesopathy is a pain caused due to inflammation of the insertion area of the Achilles tendon on the posterosuperior aspect of the calcaneus. Sometimes, isolated Achilles enthesopathy can be occurred, while, mostly, it is observed with rheumatological diseases. We herein aimed to report a case presentation, sitagliptin-induced enthesopathy, and literature review on musculoskeletal manifestations of gliptins.
View Article and Find Full Text PDFSitagliptin-induced Pancreatitis: Chronic Use Would Not Spare You the Complication.
Cureus
March 2020
Internal Medicine, Florida State University College of Medicine Internal Medicine Residency Program at Sarasota Memorial Hospital, Sarasota, USA.
Medication-induced pancreatitis is an overlooked cause of acute pancreatitis. We present an 81-year-old male patient with acute sharp epigastric pain radiating to his back, who was found to have lipase of more than 30,000 U/L. The patient denied current alcohol use.
View Article and Find Full Text PDFDPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis.
BMJ Case Rep
August 2019
Division of Rheumatology, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, Florida, USA.
Sitagliptin is a dipeptidyl peptidase-4 inhibitor commonly used in the treatment of type 2 diabetes mellitus for glycaemic control. Concerns have arisen regarding adverse events caused by this drug, particularly concerning arthralgias. Here, we report on a 56-year-old man being treated with sitagliptin who developed inflammatory arthritis after taking the drug for 6 months.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!